Table 2 Overexpression of claudin -4, MOC-31 and p16 according to primary sites of carcinoma and histological type
From: P16 as a marker of carcinoma in effusions and peritoneal washing
Carcinoma | Claudin-4 Overexpression n (TIS) | MOC-31 Overexpression n (TIS) | P16 Overexpression n (TIS) | |||
|---|---|---|---|---|---|---|
Adenocarcinomas | absence | presence | absence | presence | absence | presence |
Lung (n = 29) | 0 | 29 (6–12) | 0 | 29 (6–12) | 2 (1,4) | 27 (6–12) |
Ovary (n = 16) | 0 | 16 (8,12) | 0 | 16 (8,12) | 1 (1) | 15 (6–12) |
Breast (n = 16) | 0 | 16 (6–12) | 0 | 16 (6–12) | 4 (2,4) | 12 (8–12) |
Stomach (n = 6) | 0 | 6 (6–12) | 0 | 6 (6–12) | 2 (2,4) | 4 (8,9) |
Colon (n = 5) | 0 | 5 (6–12) | 0 | 5 (6–12) | 0 | 5 (6–12) |
Biliary tract (n = 3) | 0 | 3 (8,12) | 0 | 3 (8,12) | 0 | 3 (6) |
Cervix (n = 2) | 0 | 2 (8,12) | 0 | 2 (8,12) | 0 | 2 (12) |
Pancreas (n = 1) | 0 | 1 (12) | 0 | 1 (12) | 1 (2) | 0 |
Endometrium (n = 1) | 0 | 1 (12) | 0 | 1 (12) | 0 | 1 (12) |
Kidney (n = 1) | 0 | 1 (12) | 0 | 1 (12) | 0 | 1 (12) |
Unkonwn (n = 2) | 0 | 2 (8,12) | 0 | 2 (8,12) | 0 | 2 (12) |
Subtotal Adenocarcinomas | 0 | 82 (6–12) | 0 | 82 (6–12) | 10 (1–4) | 72 (6–12) |
Other histological types | ||||||
Squamous carcinoma (cervix) (n = 1) | 0 | 1 (9) | 1 (1) | 0 | 0 | 1 (12) |
Urothelial carcinoma (bladder) (n = 1) | 0 | 1 (12) | 1 (4) | 0 | 0 | 1 (8) |
Small cell carcinoma (lung) (n = 1) | 0 | 1 (6) | 0 | 1 (12) | 0 | 1 (8) |
Total (n = 85) | 0 | 85 | 2 | 83 | 10 | 75 |